E-Moxclav 228.5 Mg 75 ml

E-Moxclav 228.5 Mg 75 ml

Description:

E-Moxclav 228.5 mg 75 ml is a prescription oral antibiotic dry suspension containing amoxicillin and clavulanic acid, manufactured by EIPICO. After reconstitution with water, it forms a flavored suspension used to treat a wide range of bacterial infections in adults and children, especially those caused by beta-lactamase–producing organisms that are resistant to amoxicillin alone. It belongs to the penicillin class combined with a beta-lactamase inhibitor, providing broad-spectrum antibacterial coverage for respiratory, ear, sinus, skin, and urinary tract infections. This product is intended for therapeutic use under medical supervision.

Indications:

• Lower respiratory tract infections, including bronchitis and pneumonia, caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) due to beta-lactamase–producing H. influenzae and M. catarrhalis.
• Acute sinusitis caused by beta-lactamase–producing H. influenzae and M. catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (UTIs) caused by beta-lactamase–producing isolates of E. coli, Klebsiella species, and Enterobacter species.
• Other susceptible infections as determined by the prescribing physician based on culture and sensitivity results.

Active Ingredients / Key Components:

• Amoxicillin (as amoxicillin trihydrate) – part of the total 228.5 mg per dose (exact amoxicillin mg content in this strength is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).
• Clavulanic acid (as potassium clavulanate) – part of the total 228.5 mg per dose (exact clavulanic acid mg content in this strength is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).
• Total strength: 228.5 mg per measured dose (amoxicillin + clavulanic acid) in a 75 ml dry suspension bottle after reconstitution.
• Other excipients (such as suspending agents, sweeteners, flavoring agents, preservatives) are present but not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.).

Dosage & Administration / How to Use:

• This is a dry powder that must be reconstituted with clean drinking water up to the marked line on the bottle to obtain 75 ml of oral suspension. Shake well before and after adding water.
• After reconstitution, shake the bottle vigorously before each dose to ensure uniform distribution of the active ingredients.
• Dosage is usually based on body weight, age, severity of infection, and kidney function. Follow the exact dose, frequency, and duration prescribed by your doctor.
• Commonly, the suspension is given 2–3 times daily, but the exact regimen must be determined by a healthcare professional.
• It is generally recommended to take the suspension at the start of a meal to improve absorption and reduce gastrointestinal side effects.
• Use the provided measuring spoon or oral syringe to ensure accurate dosing. Do not use household teaspoons.
• Do not stop treatment early, even if symptoms improve, unless advised by your doctor, as this may lead to recurrence of infection and antibiotic resistance.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.

Clinical Benefits:

• Provides broad-spectrum antibacterial coverage against many gram-positive and gram-negative organisms, including beta-lactamase–producing strains.
• Combines amoxicillin with clavulanic acid to overcome resistance caused by beta-lactamase enzymes, improving treatment success in resistant infections.
• Effectively treats common community-acquired infections such as otitis media, sinusitis, bronchitis, pneumonia, and urinary tract infections.
• Helps relieve infection-related symptoms such as fever, pain, cough, earache, sinus pressure, and urinary burning when used as directed.

Warnings & Contraindications:

• Contraindicated in patients with a known hypersensitivity or allergy to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.
• Use with caution in patients with a history of severe allergic reactions to cephalosporins or other beta-lactam antibiotics due to possible cross-sensitivity.
• Use with caution in patients with liver impairment or a history of amoxicillin–clavulanate–associated cholestatic jaundice or hepatic dysfunction.
• Dosage adjustment may be required in patients with renal impairment; consult a doctor for appropriate dosing.
• Prolonged or repeated use may result in overgrowth of non-susceptible organisms, including fungi; if superinfection occurs, appropriate measures should be taken.
• Antibiotic-associated diarrhea and pseudomembranous colitis have been reported with many antibiotics; discontinue and seek medical advice if severe or persistent diarrhea occurs.
• Consult your doctor before use if pregnant or breastfeeding. The medicine should be used during pregnancy or lactation only if clearly needed and prescribed.
• Inform your doctor about all other medications you are taking, especially anticoagulants (e.g., warfarin), allopurinol, methotrexate, or other antibiotics, due to potential interactions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects: nausea, vomiting, mild diarrhea, abdominal discomfort, and soft stools.
• Possible skin reactions: rash, itching, urticaria (hives). Discontinue and seek medical advice if any skin reaction occurs.
• Less common side effects: headache, dizziness, changes in taste, or oral/vaginal candidiasis (thrush).
• Serious but rare side effects: severe allergic reactions (anaphylaxis), angioedema, severe skin reactions, jaundice, liver dysfunction, severe or bloody diarrhea (possible pseudomembranous colitis), and convulsions in predisposed patients.
• Seek immediate medical attention if you experience difficulty breathing, swelling of the face or throat, severe skin rash, yellowing of the skin or eyes, or persistent severe diarrhea.

Storage Instructions:

Store the unopened dry powder bottle below 25°C in a cool, dry place away from direct sunlight and moisture. After reconstitution, store the suspension in a refrigerator if recommended by the manufacturer (usually 2–8°C) and use within the period stated on the package (commonly 7–10 days). Do not freeze. Keep container tightly closed and keep out of reach of children.

Specifications:

• Product form: Dry powder for oral suspension (syrup after reconstitution).
• Strength: 228.5 mg (amoxicillin + clavulanic acid) per measured dose (exact ratio not specified in available information).
• Volume after reconstitution: 75 ml oral suspension.
• Route of administration: Oral.
• Intended use: Prescription antibiotic medicine for bacterial infections under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.